webinar register page

Webinar banner
Combination Aspirin & DOAC Therapy Increases Bleeding Risk
From the multi-center MAQI consortium, the authors explored the increased risk of bleeding when patients who were prescribed DOAC medications also were taking aspirin therapy.

Learn more about how the data was collected, how the analyses were conducted, and what steps are being taken to reduce unnecessary aspirin use in order to try and reduce bleeding complications.

Jordan Schaefer, MD
Geoffrey Barnes, MD, MSc

Arthur Allen, PharmD, CACP
Tracy Minichiello, MD

Link to Article: https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2778963

We are pleased to provide enduring accreditation for this webinar!

Jul 21, 2021 12:00 PM in Eastern Time (US and Canada)

* Required information